Eric GreenSenior Vice President, General Manager, TTR Franchise at Alnylam Pharmaceuticals
Eric Green joined Alnylam in 2015 and is currently Senior Vice President and General Manager of the TTR Program, comprising ONPATTRO (patisiran) and vutrisiran. He has lead the TTR program through pivotal clinical development, global regulatory submissions and ongoing global commercial launches. Previously, Eric worked at Synageva BioPharma, where he was Vice President of Program and Alliance Management. In that role he was responsible for the oversight, management, and leadership of the company’s lead compound being developed as an enzyme replacement therapy for an ultra-orphan genetic disease. Prior to Synageva, he worked in roles of increasing scope and responsibility at Infinity Pharmaceuticals and at Genzyme Corporation. Eric received his Bachelor of Science in Chemical Engineering from the University of Michigan, a Masters in Chemical Engineering from the Massachusetts Institute of Technology (MIT), and a MBA from the MIT Sloan School of Management.